Cargando…
Radium and other alpha emitters in prostate cancer
(223)Radium ((223)Ra) is the first alpha-emitting therapy proven effective in human cancer. Prospective randomized trials indicate that (223)Ra, which concentrates after intravenous injection in areas of osteoblastic metastatic disease, can prolong survival in bone-dominant castrate resistant prosta...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043743/ https://www.ncbi.nlm.nih.gov/pubmed/30050802 http://dx.doi.org/10.21037/tau.2018.02.07 |